Office Assessed Blood Pressure and Ambulatory Blood Pressure Monitoring in Chronic Kidney Disease Patients Versus Kidney Transplant Recipients

Open access

Abstract

How reliable is office assessed blood pressure (BP) in chronic kidney disease (CKD) patients and kidney transplant (KTx) recipients is yet to be determined, although the diagnosis of arterial hypertension has been based on these measurements. The aim of this study was to investigate the potential differences between office assessed BP and ambulatory blood pressure monitoring (ABPM) in CKD patients and KTx recipients. We conducted a prospective study which enrolled 45 patients. Morning and evening seated office BPs were assessed using a sphygmomanometer at 5 consecutive outpatient visits. A mean systolic BP (SBP) and diastolic BP (DBP) was calculated. Ambulatory blood pressure was measured over 24 hours using a Meditech ABPM-05 device. Office SBP was statistically significant higher in CKD patients than KTx recipients both in the morning and evening (p=0.0433 and p=0.0066 respectively). ABPM showed higher night-time SBPs (p=0.0445) and higher overall, day-time and night-time DBPs in KTX recipients (p=0.0001, p=0.0006, p<0.0001 respectively). In CKD patients, office SBPs and DBPs are significantly higher than overall SBPs and DBPs as assessed by 24hr ABPM. Office BP monitoring as assessed by clinician is acceptable but tends to overestimate BP in both CKD and KTx study groups.

1. Opelz G, Wujciak T, Ritz E - Association of chronic kidney graft failure with recipient blood pressure. Kidney International, 1998; 53:217–222.

2. Mange KC, Cizman B, Joffe M, Feldman HI - Arterial hypertension and renal allograft survival. Journal of the American Medical Association, 2000;283:633–638.

3. Stenehjem AE, Gudmundsdottir H, Os I - Office blood pressure measurements overestimate blood pressure control in renal transplant patients. Blood Pressure Monitoring, 2006;11:125–133.

4. Iimuro S, Imai E, Watanabe T, et al - Chronic Kidney Disease Japan Cohort Study Group. Clinical correlates of ambulatory BP monitoring among patients with CKD, 2013;8:721-730.

5. Czyżewski Ł, Wyzgał J, Kołek A - Evaluation of selected risk factors of cardiovascular diseases among patients after kidney transplantation, with particular focus on the role of 24-hour automatic blood pressure measurement in the diagnosis of hypertension: an introductory report. Ann Transplant, 2014;19:188-198.

6. Sarafidis PA, Rumjon A, Macdougall IC - Ambulatory blood pressure monitoring:An Invaluable Tool Comes of Age for Patients with Chronic Kidney Disease? Am J Nephrol, 2012;35:238–241.

7. Wang J, Guo R, Liu S, et al - Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients, 2014;127:3645-3650.

8. Xue W, Zhang Q, Xu Y, Wang W, Zhang X, Hu X - Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis. Chin Med J (Engl), 2014;127:2376-2381.

9. Ponticelli C, Cucchiari D, Graziani G. - Hypertension in kidney transplant recipients. Transpl Int, 2011;24:523-533.

10. Parati G, Stergiou G, O’Brien E, et al - European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens, 2014;32:1359-1366.

11. Paoletti E, Gherzi M, Amidone M, Massarino F, Cannella G - Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation, 2009;87:1864–1869.

12. SarafidisPA, Sharpe CC, Wood E, et al - Prevalence, patterns of treatment, and control ofhypertensionin predialysis patients with chronic kidney disease. Nephron Clin Pract, 2012;120:c147-155.

13. Farag YM, Mittal BV, Keithi-Reddy SR, et al - Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol, 2014;15:42.

14. Alani H, Tamimi A, Tamimi N, et al - Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol, 2014;3:156-168.

15. White WB - Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med, 2003;348:2377–2378.

16. Mancia G, Fagard R, Narkiewicz K, et al - 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). .J Hypertens, 2013;31:1281-357.

17. Burnier M, Pruijm M, Wuerzner G, Santschi V - Drug adherence in chronic kidney diseases and dialysis. Nephrol Dial Transplant, 2015;30:39-44.

18. David VG, Yadav B, Jeyaseelan L, Deborah MN, et al - Prospective blood pressure measurement in renal transplant recipients. Indian J Nephrol, 2014;24:154-160.

19. Ahmed J, Ozorio V, Farrant M, Van Der Merwe W - Ambulatory vs Office Blood Pressure Monitoring in Renal Transplant Recipients. J Clin Hypertens (Greenwich), 2014; doi: 10.1111/jch.12448.

20. Campistol JM, Romero R, Paul J, Gutiérrez-Dalmau A - Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant, 2004;19(suppl 3):iii62-iii66.

21. Castillo-Lugo JA, Vergne-Marini P - Hypertension in kidney transplantation. Semin Nephrol, 2005;25:252-260.

22. Barbari A. - Posttransplant hypertension: multipathogenic disease process. Exp Clin Transplant, 2013;11:99-108.

Acta Medica Marisiensis

The Journal of The University of Medicine and Pharmacy of Targu-Mures

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 216 216 81
PDF Downloads 213 213 93